337 related articles for article (PubMed ID: 26320450)
1. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
2. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
3. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan.
Fong Y; Chou SJ; Hung KF; Wu HT; Kao SY
J Chin Med Assoc; 2008 Mar; 71(3):123-7. PubMed ID: 18364263
[TBL] [Abstract][Full Text] [Related]
5. Lack of elevated HER2/neu expression in epithelial dysplasia and oral squamous cell carcinoma in Iran.
Seifi S; Shafaei SN; Nosrati K; Ariaeifar B
Asian Pac J Cancer Prev; 2009; 10(4):661-4. PubMed ID: 19827890
[TBL] [Abstract][Full Text] [Related]
6. Salivary Levels of ErbB2 and CEA in Oral Squamous Cell Carcinoma Patients.
Honarmand MH; Farhad-Mollashahi L; Nakhaee A; Nehi M
Asian Pac J Cancer Prev; 2016; 17(S3):77-80. PubMed ID: 27165212
[TBL] [Abstract][Full Text] [Related]
7. Investigating the level of salivary endothelin-1 in premalignant and malignant lesions.
Nosratzehi T; Risbaf Fakour S; Alijani E; Salehi M
Spec Care Dentist; 2017 May; 37(3):134-139. PubMed ID: 28199027
[TBL] [Abstract][Full Text] [Related]
8. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
Metgud R; Bajaj S
Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
[TBL] [Abstract][Full Text] [Related]
9. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.
Zanotti L; Paderno A; Piazza C; Pagan E; Bignotti E; Romani C; Bandiera E; Calza S; Del Bon F; Nicolai P; Ravaggi A
Laryngoscope; 2017 Nov; 127(11):E408-E414. PubMed ID: 28782189
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of salivary sialic acid as a tumor marker in tobacco chewers with oral cancer.
Azeem MS; Yesupatham ST; Mohiyuddin SMA; Sumanth V; Ravishankar S
J Cancer Res Ther; 2020; 16(3):605-611. PubMed ID: 32719275
[TBL] [Abstract][Full Text] [Related]
12. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
13. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
14. Expression of HER-2/neu in Oral Squamous Cell Carcinoma.
Mirza S; Hadi N; Pervaiz S; Zeb Khan S; Mokeem SA; Abduljabbar T; Al-Hamoudi N; Vohra F
Asian Pac J Cancer Prev; 2020 May; 21(5):1465-1470. PubMed ID: 32458657
[TBL] [Abstract][Full Text] [Related]
15. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
16. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
17. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
19. HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated.
Sardari Y; Pardis S; Tadbir AA; Ashraf MJ; Fattahi MJ; Ebrahimi H; Purshahidi S; Khademi B; Hamzavi M
Asian Pac J Cancer Prev; 2012; 13(6):2891-6. PubMed ID: 22938479
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.
Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M
J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]